Trial Profile
Teriflunomide Observational Effectiveness Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2021
Price :
$35
*
At a glance
- Drugs Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 17 Aug 2021 Status changed from recruiting to completed.
- 23 May 2017 Planned End Date changed from 1 Jul 2018 to 1 Dec 2019.
- 23 May 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2018.